|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.6 HKD | -0.62% |
|
+0.63% | -18.78% |
| Mar. 28 | Hua Medicine Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Hua Medicine Ltd. Appoints Yi Zhang as Executive Director with Effect from January 1, 2024 | CI |
Hua Medicine (Shanghai) Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 70.33 million. Net loss was CNY 90.1 million compared to CNY 104.62 million a year ago.
Basic loss per share from continuing operations was CNY 0.09 compared to CNY 0.11 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -18.78% | 202M | |
| +9.15% | 106B | |
| -1.08% | 104B | |
| +7.71% | 23.25B | |
| -11.55% | 22.5B | |
| -7.24% | 18.7B | |
| -37.08% | 17.95B | |
| -9.91% | 16.99B | |
| +7.55% | 14.26B | |
| +40.04% | 12.76B |
HUA MEDICINE (SHANGHAI) LTD. 